This website will be updated with COVID-19 information relating to sponsored research activities in the School of Medicine. Below, you will find guidance from the University and School of Medicine, NIH and other federal agencies, and non-profit sponsors regarding proposals, clinical trials, progress reports and award management of projects impacted by COVID-19. In addition, a listing of current funding opportunities for COVID-19 research is also provided.
ORA & RMG COVID-19 Sponsored Projects Town Hall Webinars
The ORA & RMG town hall initially scheduled for August 19, 2020 has been postponed. The new date will be updated on this page and an announcement will be sent to ORA Updates, ABC, and SMART email distribution lists.
ORA and the Research Management Group hosted several town halls on COVID-19's impact on sponsored research administration. ORA and RMG leadership addressed concerns and provided guidance on the shifting research administration landscape due to the pandemic. Recordings of the April 7, April 28, May 12, June 2 and July 14 webinars are available. (SUNet ID required).
Guidance for Sponsored Research
Funding Opportunities Specific to COVID-19
Unless otherwise stated, faculty with PI eligibility (those with UTL, MCL, NTLR appointments) and Clinician Educator (CE) faculty (with an approved CE PI waiver) are considered eligible by Stanford policies.
Standard proposal submission guidelines must be followed for all COVID-19 funding opportunities. School of Medicine PIs: Please submit your Proposal Intake Form (PIF) to initiate the proposal process.